 NEW ORLEANS--BUSINESS WIRE--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick Foti, LLC KSF are investigating the proposed sale of Acceleron Pharma Inc. NasdaqGM: XLRN to Merck NYSE: MRK. Under the terms of the proposed transaction, shareholders of Acceleron will receive only 180 in cash for each share of Acceleron that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or wh 